Median Technologies Names Oran Muduroglu President of U.S. Subsidiary Median eyonis Inc

Reuters
02/19
Median Technologies Names Oran Muduroglu President of U.S. Subsidiary Median eyonis Inc

Median Technologies SA has appointed Oran Muduroglu as President of Median eyonis Inc., its U.S. subsidiary, to lead the U.S. launch and scale-up of the eyonis® LCS lung cancer screening software. Median eyonis Inc. is expanding U.S. commercial and clinical support teams and will pursue a phased national rollout, including distribution partnerships such as a non-exclusive agreement with Tempus AI to integrate eyonis® LCS into Tempus’ Pixel platform.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Median Technologies SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20260218440005) on February 18, 2026, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10